The ESCO2 Gene Roberts Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ESCO2 gene, which are responsible for Roberts Syndrome. This rare genetic disorder is characterized by growth delays, abnormalities in limb and facial development, and other systemic complications. By analyzing a patient's DNA, the test can confirm a diagnosis of Roberts Syndrome, which is crucial for managing the condition and offering genetic counseling to families.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect the specific gene mutations. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures reliability and confidentiality. Given the rarity of Roberts Syndrome, this genetic test plays a pivotal role in early detection and intervention, ultimately improving the quality of life for affected individuals.
The WNT5A gene plays a crucial role in the development of various body structures, including bones and other tissues. Mutations in the WNT5A gene are associated with Robinow Syndrome, a rare genetic disorder characterized by skeletal dysplasia, which includes short stature, limb abnormalities, genital hypoplasia, and distinctive facial features. Robinow Syndrome is classified into autosomal dominant and autosomal recessive types, with the autosomal dominant type 1 (AD1) being linked to mutations in the WNT5A gene.
To diagnose Robinow Syndrome AD1, a genetic test focusing on the WNT5A gene is available at DNA Labs UAE. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding management and treatment plans. The test involves analyzing the patient's DNA to identify mutations in the WNT5A gene that are known to cause the condition.
The cost of the WNT5A Gene Robinow Syndrome Autosomal Dominant Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring accurate and reliable results. By opting for this test, individuals suspected of having Robinow Syndrome or families with a history of the condition can gain valuable insights into their genetic makeup, facilitating informed decisions regarding health and family planning.
The DVL1 Gene Robinow Syndrome Autosomal Dominant Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, aimed at identifying mutations in the DVL1 gene. These mutations are responsible for the autosomal dominant form of Robinow Syndrome, a rare genetic disorder characterized by skeletal abnormalities, distinctive facial features, and dental problems. The test plays a crucial role in the early detection and management of the syndrome, allowing for timely intervention and support for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately diagnose this complex condition. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect high-quality services and reliable results, contributing to better health outcomes for those affected by Robinow Syndrome.
Robinow Syndrome is a rare genetic disorder characterized by skeletal dysplasia, which includes short stature, limb shortening, genital hypoplasia, and facial abnormalities. The ROR2 gene plays a crucial role in the development of the skeletal and genital systems, and mutations in this gene are associated with the autosomal recessive form of Robinow Syndrome. Identifying mutations in the ROR2 gene can confirm a diagnosis of Robinow Syndrome and help in understanding the condition's severity and potential management strategies.
At DNA Labs UAE, individuals can undergo a genetic test specifically designed to identify mutations in the ROR2 gene, which is pivotal for diagnosing autosomal recessive Robinow Syndrome. The test is comprehensive and ensures accuracy in detecting the genetic anomaly responsible for the syndrome.
The cost of the ROR2 Gene Robinow Syndrome Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable resource for families seeking answers about this rare condition, enabling informed decisions regarding health and family planning. It's important to note that consultation with a healthcare provider or a genetic counselor is recommended to interpret the test results accurately and to understand the implications for the individual and their family.
The "TWIST1 Gene Robinow-Sorauf Syndrome Genetic Test" is a specialized diagnostic procedure conducted at DNA Labs UAE, designed to identify mutations in the TWIST1 gene that are associated with Robinow-Sorauf Syndrome. This condition is a rare genetic disorder characterized by craniofacial abnormalities, such as a prematurely fused skull (craniosynostosis), distinctive facial features, and dental anomalies. The test plays a critical role in the accurate diagnosis of the syndrome, enabling healthcare providers to offer appropriate treatments and genetic counseling. Priced at 4400 AED, this test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic alterations in the TWIST1 gene. The results from this test can provide valuable information for affected individuals and their families regarding the management of the syndrome and the risk of passing it on to future generations.
The CREBBP Gene Rubinstein-Taybi Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the CREBBP gene, which are associated with Rubinstein-Taybi Syndrome (RTS). RTS is a rare genetic disorder characterized by distinctive facial features, broad thumbs and toes, short stature, and varying degrees of intellectual disability. The test plays a crucial role in the early diagnosis and management of RTS, enabling targeted interventions and support for affected individuals.
Performed using advanced genetic sequencing techniques, this test analyzes the CREBBP gene for specific mutations that lead to the syndrome. Given the complexity of the disorder and the gene involved, this test is a critical tool for genetic counselors and healthcare providers in confirming a diagnosis of Rubinstein-Taybi Syndrome, thus facilitating appropriate medical and developmental interventions.
The cost of the CREBBP Gene Rubinstein-Taybi Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CREBBP gene. For families and individuals undergoing this testing, it represents a significant step towards understanding their genetic health and making informed decisions about their care and management.
The EP300 gene test for Rubinstein-Taybi Syndrome (RTS) is a specialized genetic examination aimed at identifying mutations in the EP300 gene, which is one of the genes known to cause RTS. Rubinstein-Taybi Syndrome is a rare genetic disorder characterized by intellectual disability, distinctive facial features, and broad thumbs and toes. The EP300 gene plays a critical role in regulating gene activity and is essential for normal development.
Conducted at DNA Labs UAE, this genetic test is a crucial tool for diagnosing RTS, particularly in individuals who exhibit the syndrome's symptoms but do not have a mutation in the more commonly associated CREBBP gene. Early diagnosis through this test can facilitate timely intervention and management of the condition, helping improve the quality of life for those affected.
The cost of the EP300 gene test for Rubinstein-Taybi Syndrome at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the EP300 gene that could indicate the presence of RTS. Given the complexity and the specialized nature of this test, it represents a significant step forward in personalized medicine and genetic understanding of developmental disorders.
The FGFR2 Gene Saethre-Chotzen Syndrome Genetic Test is a specialized diagnostic procedure designed to detect mutations in the FGFR2 gene, which are associated with Saethre-Chotzen Syndrome (SCS). Saethre-Chotzen Syndrome is a congenital condition characterized by craniosynostosis (premature fusion of skull bones), leading to abnormal skull shape, facial asymmetry, and potentially impacting brain development. Other features may include minor limb abnormalities and partial webbing of the fingers or toes. The condition varies in severity and other manifestations can include short stature, hearing loss, and dental problems.
This genetic test involves analyzing the patient's DNA to identify mutations in the FGFR2 gene that are known to cause Saethre-Chotzen Syndrome. Early and accurate diagnosis through this test can enable appropriate medical intervention, guidance for family planning, and genetic counseling for affected families.
The test is available at DNA Labs UAE, a leading facility specializing in genetic and molecular diagnostics. The cost of the FGFR2 Gene Saethre-Chotzen Syndrome Genetic Test is 4400 AED. Conducted in a state-of-the-art laboratory by skilled geneticists and technicians, this test offers families vital information for the management of the syndrome, potentially improving the quality of life for those affected.
The TWIST1 gene Saethre-Chotzen Syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the TWIST1 gene, which are linked to Saethre-Chotzen Syndrome (SCS). This syndrome is a congenital condition characterized by craniosynostosis (premature fusion of skull bones), leading to distinctive facial features and potentially affecting fingers and toes. The test is crucial for early diagnosis and management of the syndrome, allowing for timely interventions to address developmental challenges and physical abnormalities associated with SCS.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test provides a comprehensive analysis of the TWIST1 gene to detect any anomalies that could indicate the presence of Saethre-Chotzen Syndrome. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. By opting for this test at DNA Labs UAE, individuals can expect reliable results, which are essential for families seeking to understand their genetic health and make informed decisions regarding treatment and management of the syndrome.
The ESCO2 gene SC Phocomelia syndrome genetic test is a specialized diagnostic procedure aimed at detecting mutations in the ESCO2 gene, which are responsible for causing Roberts Syndrome (RBS) or SC phocomelia syndrome. This rare genetic disorder is characterized by limb and facial abnormalities, growth retardation, and other developmental issues. The test involves analyzing the DNA to identify any genetic alterations in the ESCO2 gene that could lead to the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures high accuracy and reliability. The cost of the ESCO2 gene SC Phocomelia syndrome genetic test is 4400 AED. This test is crucial for families with a history of the syndrome, offering them valuable information regarding genetic risk, aiding in early diagnosis, and facilitating appropriate management and intervention strategies for affected individuals.
